上睑下垂
神经炎症
促炎细胞因子
药理学
标记法
神经保护
炎症体
电针
内斯汀
化学
细胞凋亡
医学
炎症
细胞生物学
生物
内科学
神经干细胞
病理
生物化学
针灸科
干细胞
替代医学
作者
Wanqing Lin,Zhaolian Cai,Xiaoyong Zhong,Xiaofang You,Ronghui Yu,Bin Chen
标识
DOI:10.1136/svn-2024-003964
摘要
Background We investigated the potential contribution of the lncRNA Neat1 to the therapeutic efficacy of electroacupuncture (EA) after ischaemic stroke. Methods EA stimulation was used to treat cerebral ischaemia/reperfusion injury (CIRI) in the rat model. Post-therapeutic intervention, infarct volume (IV), brain water content and neurological impairments were assessed. Furthermore, TUNEL and immunofluorescence staining were performed to examine cellular apoptosis, neuronal loss and neuroglial activation. Additionally, Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR), western blotting, ELISA and electron microscopy were employed to assess the NLRC4 inflammasome pathway and neuronal pyroptosis in rats subjected to CIRI. Results Present findings confirmed that EA successfully downregulated Neat1 and IV in response to CIRI. Moreover, the positive impacts of EA on neurobehavioural recovery, suppression of brain damage and reduction in MAP2 degradation were reversed by Neat1 overexpression. Neat1 overexpression also blocked the reduction in NLRC4 activation, including that of components such as NLRC4, Caspase-1 and gasdermin D, as well as the decrease in cellular apoptosis and neuronal pyroptosis induced by EA. Furthermore, Neat1 overexpression counteracted the suppressive effects of EA on proinflammatory microglial polarisation (Iba1 + /CD11b + ) and increased neurogenesis (Nestin + /Sox2 + ) in EA-treated rats. Finally, Neat1 overexpression inhibited the ability of EA to lower proinflammatory factors and elevated anti-inflammatory cytokines in the ischaemic striatum. Conclusions These results highlight a novel anti-inflammatory mechanism of EA that involves the lncRNA Neat1/NLRC4 pathway, which regulates the inhibition of neuronal pyroptosis and neuroinflammation. This mechanism may work as an attainable therapeutic objective for EA-induced neuroprotection against ischaemic stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI